Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Medtronic
Johnson and Johnson
Dow
Healthtrust
Fish and Richardson
US Army
AstraZeneca
Novartis

Generated: December 12, 2017

DrugPatentWatch Database Preview

TESTIM Drug Profile

« Back to Dashboard

When do Testim patents expire, and what generic alternatives are available?

Testim is a drug marketed by Auxilium Pharms Llc and is included in one NDA. There are ten patents protecting this drug and one Paragraph IV challenge.

This drug has forty-six patent family members in twenty-nine countries.

The generic ingredient in TESTIM is testosterone. There are sixty-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Drug patent expirations by year for TESTIM

Pharmacology for TESTIM

Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

Medical Subject Heading (MeSH) Categories for TESTIM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcTESTIMtestosteroneGEL;TRANSDERMAL021454-001Oct 31, 2002AB2RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for TESTIM

Drugname Dosage Strength RLD Submissiondate
testosteroneGel1%Testim8/21/2008

International Patent Family for Tradename: TESTIM

Country Document Number Estimated Expiration
Saudi Arabia1707► Subscribe
Brazil0309390► Subscribe
European Patent Office1741433► Subscribe
Norway20045019► Subscribe
South Africa200408422► Subscribe
Iceland7535► Subscribe
Argentina087484► Subscribe
MexicoPA04010311► Subscribe
Hong Kong1098386► Subscribe
New Zealand535970► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cipla
Chinese Patent Office
US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
AstraZeneca
McKesson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot